Main Article Content
Malignant neoplasms of salivary glands are rare, accounting for 6% of all head and neck malignancy. Incidence of primary squamous cell carcinoma of parotid gland is 0.3% to 1.5%. Squamous cell carcinoma of parotid gland is an aggressive malignancy seen mostly in adults in their 5th or 6th decade of life. Here we report a case of primary squamous cell carcinoma of parotid gland in a 29 years old, male patient. He hadaninfra-auricular swelling on right side of face progressively increasing in size since the age of 6 years and he had facial nerve paralysis since 10 years of age. Patient was diagnosed with squamous cell carcinoma of parotid gland at the age of 29 years. He underwent total parotidectomy without neck dissection elsewhere. Recurrence of tumour was there at the primary site within five months of the treatment of primary tumour. Recurrent tumour was treated successfully by wide local excision with level I-V neck dissection. Reconstruction was done with pectoralis major myo-cutaneous flap and patient had post-operative radiotherapy and chemotherapy.
Batsakis JG, Mc Clatchey KD, Johns M, Regazi J. Primary squamous cell carcinoma of the parotid gland. Arch Otolaryngol. 1976;102:356-7.
Schmidt RL, Hall BJ, Wilson AR, Layfield LJ. A systematic review and meta-analysis of the diagnostic accuracy of fine-needle aspiration cytology for parotid gland lesions. Am J Clin Pathol. 2011;136:45-59.
Katoch Y, Ishige T; Kasai M, Naitoh J, Kaneko T, Kitamura T et al. Malignant Parotid gland tumour and facial nerve paralysis. Arch Otorhinolaryngol. 1984; 240:139-44.
Cheuk W, Chan JKC. Salivary Gland tumour. In: Fletcher CDM ed. Diagnostic Histopathology of tumours 2nd ed Philadelphia: Churchill Livingstone. 2000; 287-303.
Yu Lan Mary Ying, Jonas T Johnsan, Eugene N. Myers. Squamous cell carcinoma of parotid gland, Wiley InterScience
DOI:10.1002/hed.20360vvc2006 wiley periodicals, Inc.
Alterio D, Jereczek-Fossa BA, Griseri M, D’onofrio A, Giugliano G, Fiore MR et al. Three dimensional conformal postoperative radiotherapy in patients with parotid tumour 10 year experience at the European institute of oncology. Tumori. 2011;97(3):328-34.
Goud SCC, Varshney S, Joshi P, Malhotra M, Pandey A, Potluri P. Basal Cell Adenocarcinoma of Parotid Gland. Online J Health Allied Scs. 2018;17(4): 10.